Microba Life Sciences Limited (ASX:MAP)
Australia
· Delayed Price · Currency is AUD 0.0820
0.00 (0.00%)
At close: Mar 6, 2026
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 49.93 million as of March 6, 2026. Its market cap has decreased by -57.12% in one year.
Market Cap
49.93M
Enterprise Value
41.20M
Revenue
14.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 49.93M, a decrease of -48.00%. That is a compound annual growth rate of -15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 49.93M | 7.89% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INOVIQ | 46.46M |
| BCAL Diagnostics | 44.17M |
| Cryosite | 58.57M |
| Rhythm Biosciences | 60.66M |
| Genetic Signatures | 21.58M |
| Imagion Biosystems | 9.81M |
| Monash IVF Group | 257.16M |
| Australian Clinical Labs | 416.48M |